Virax Biolabs Group Ltd Depreciation Expense
Virax Biolabs Group Ltd (VRAX) reported Depreciation Expense of $266.60 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DepreciationExpense · last filed 2025-07-02
| Period end | Depreciation Expense 12 month |
|---|---|
| 2025-03-31 | $266.60K 20-F · filed 2025-07-02 |
| 2024-03-31 | $54.87K 20-F · filed 2025-07-02 |
| 2023-03-31 | $0.00 20-F · filed 2025-07-02 |
| 2022-03-31 | $0.00 20-F · filed 2024-08-20 |